Live feed
Filing
SC 13G
SC 13G0000899140-21-000633·Point72 Asset Management, L.P.
Schedule 13G ownership disclosure
THERAVANCE BIOPHARMA INC
Security class unavailable · CUSIP: G8807B106
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,035,231
- Percent of class
- 6.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-21-000633
- Form type
- SC 13G
- Filer
- Point72 Asset Management, L.P.
- CIK
- CIK 1603466
- Filed
- Sep 07, 2021
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership